Deep Track Capital’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.3M	Sell	1,393,944 -1,130,889	-45%	-$33.6M	0.56%	46
2025 Q4	$78.6M	Sell	2,524,833 -2,855,616	-53%	-$78.3M	1.79%	19
2025 Q3	$116M	Hold	5,380,449	–	–	3.24%	12
2025 Q2	$75.2M	Hold	5,380,449	–	–	2.42%	14
2025 Q1	$72.5M	Buy	5,380,449 +857,708	+19%	+$14.6M	2.35%	13
2024 Q4	$86.7M	Buy	4,522,741 +771,796	+21%	+$16.8M	3.25%	9
2024 Q3	$85.3M	Sell	3,750,945 -172,904	-4%	-$2.83M	2.72%	15
2024 Q2	$51M	Buy	3,923,849 +467,796	+14%	+$6.48M	1.52%	27
2024 Q1	$60.5M	Sell	3,456,053 -175,675	-5%	-$3.41M	1.74%	22
2023 Q4	$79.1M	Buy	3,631,728 +668,461	+23%	+$10.6M	2.77%	11
2023 Q3	$45.5M	Buy	2,963,267 +1,683,765	+132%	+$32.1M	1.76%	21
2023 Q2	$30.4M	Buy	1,279,502 +49,243	+4%	+$1.26M	1.42%	21
2023 Q1	$31.3M	Sell	1,230,259 -540,895	-31%	-$17.3M	1.33%	27
2022 Q4	$51.7M	Sell	1,771,154 -199,136	-10%	-$4.59M	2.26%	18
2022 Q3	$40.4M	Buy	1,970,290 +800,000	+68%	+$14.4M	2%	18
2022 Q2	$13.5M	Hold	1,170,290	–	–	0.94%	34
2022 Q1	$21.6M	Sell	1,170,290 -166,400	-12%	-$3.2M	1.4%	27
2021 Q4	$26.4M	Buy	+1,336,690	New	+$24.9M	1.95%	20